Antianginal Drugs Claro M. Isidro M.D.
Definition of terms Angina Pectoris  – is the principal symptoms of patient with ischemic heart disease. Manifested by sudden, severe, pressing substernal pain that often radiates to the left shoulder and along the flexor surface of the left arm. Usually  precipitated by exercise, excitement or a heavy meal.
Types of Angina Typical Angina ( Classical Angina ) pain is commonly induced by exercise, excitement or a heavy meal secondary to advanced atherosclerosis of the coronary vessels associated with ST-segment depression on ECG
Variant Angina ( Prinzmetal Angina) pain is induced while at rest associated with ST-segment elevation on ECG  secondary to vasospasm of the coronary vessels Unstable angina may involve coronary spasm and may also have the component of atherosclerosis the duration of manifestation is longer than the first two and has the manifestation of Myocardial infarction
*  Myocardial ischemia which produces angina results from imbalances in myocardial oxygen supply & demand relationship such as decreased oxygen supply and/or increased oxygen demand.   Etiology   Decrease  oxygen supply Increase demand for oxygen
Determinant of Myocardial Oxygen Supply Coronary blood flow Determined by: perfusion pressure duration of diastole coronary bed resistance Arterio-venous oxygen difference
Determinant of Myocardial Oxygen demand Major Determinants Wall stress  intraventricular pressure ventricular volume wall thickness Heart rate Contractility
Determinants of Vascular Tone Relaxation of vascular smooth muscle by: Increase cGMP Decrease intracellular calcium Increase cAMP Stabilizing or preventing depolarization of the vascular smooth muscle cell membrane
Treatment Plan: A. decrease the risk factor like atherosclerosis,  hypertension, smoking B. increase oxygen supply C. decrease oxygen demand
ANTIANGINAL DRUGS I. AGENTS WHICH  ↓ O2 DEMAND & ↑ O2 SUPPLY A. NITRATES B. CALCIUM CHANNEL BLOCKERS II. AGENTS WHICH ↓ O2 DEMAND C. BETA BLOCKERS
NITRATES AND NITRITES Classification of nitrates : Rapidly acting nitrates * used to terminate acute attack of angina * e.g.-  Nitroglycerin and Amyl nitrate   * usually administered sublingually Long acting nitrates * used to prevent an attack of angina * e.g. - Erythrytyl tetranitrate, Isosorbide dinitrate, Pentaerythrytol tetranitrate   * administered orally or topically
Nitrates Coronary artery dilatation Decrease coronary bed resistance (Relieved coronary vasospasm) Increase coronary blood flow Increase oxygen supply
Nitrates Reduction on peripheral resistance (Secondary to dilatation of aorta) Decrease blood pressure Decrease after load  Decrease workload  Decrease oxygen consumption
Nitrates Reduced venous return (Due to dilatation of the veins) Decrease left ventricular volume Decrease preload  Decrease workload  Decrease oxygen consumption
Effects Coronary artery dilatation Reduction of peripheral arterial resistance – decrease after load Reduce venous return – decrease preload
Potential Beneficial Effects of Nitrates.   Beneficial effects Results Decrease Ventricular vol. Decrease myocardial oxygen requirement Decrease arterial pressure Decrease ejection time Venodilatation of epicardial coronary art. Relief of coranary artery spasm Increase collateral flow due to venodilatation Increase perfusion to ischemic myocardium Decrease left ventricular pressure   > decrease preload due to dilatation of the vein > decrease after load due to dilatation of the arteries Improved subendocardial perfusion
Potential Deleterious Effects Deleterious Effects   Results Reflex tachycardia Increase myocardial oxygen requirement   Reflex increase in contractility   Decrease diastolic perfusion   Decrease myocardial perfusion
ROUTES OF ADMINISTRATION 1. Sublingual route  – rational and effective for the treatment of acute attacks of angina pectoris. Half-life depend only on the rate at which they are delivered to the liver. 2. Oral route  – to provide convenient and prolonged prophylaxis against attacks of angina 3. Intravenous Route  – useful in the treatment of coronary vasospasm and acute ischemic syndrome. 4. Topical route  – used to provide gradual absorption of the drug for prolonged prophylactic purpose .
Drug Usual single dose Route of administration Duration of action Short acting Nitroglycerin 0.15-1.2 mg sublingual 10 - 30 min Isosorbide dinitrate 2.5-5 mg sublingual 10 – 60 min Amyl nitrite 0.18 – 3 ml  inhalation 3 – 5 min Long acting Nitroglycerin sustained action 6.5 – 13 mg q 6-8 hrs oral 6 – 8 hrs Nitroglycerin 2% ointment 1 – 1.5 inches q hr topical 3 – 6 hrs Niroglycerin slow released 1 –2 mg per 4 hrs Buccal mucosa 3 – 6 hrs Nitroglycerin slow released   10 – 25 mg /24hrs (one patch/day}   transdermal   8 –10 hrs   Isosorbide dinitrate   2.5 – 10 mg per 2 hrs sublingual   1.5 – 2 hrs   Isosorbide dinitrate 10 –60 mg per 4-6 hrs   oral   4 – 6 hrs   Isosorbide dinitrate chewable   5 – 10 mg per 2-4 hrs oral   2 – 3 hrs   Isosorbide mononitrate   20 mg per 12 hrs   oral   6 –10 hrs
Adverse Effects Throbbing headache Flushing of the face Dizziness – especially at the beginning of treatment Postural Hypotension – due to pooling of blood in the dependent portion of the body
Contraindication Renal ischemia Acute myocardial infarction Patients receiving other antihypertensive agent
B-Blockers Hemodynamics Effects   Decrease heart rate Reduced blood pressure and cardiac contractility without appreciable decrease in cardiac output
B-Blockers Decrease heart rate & Contractility Increase duration of diastole  Decrease workload  Increase coronary blood flow  Decrease O 2  consumption Increase oxygen supply
Contraindication Congestive heart failure Asthma Complete heart block
Ca - Channel Blockers Effects Coronary artery dilatation Reduction on peripheral arterial resistance – decrease after load
Ca Channel Blockers Coronary artery dilatation Decrease coronary bed resistance (Relieved coronary vasospasm) Increase coronary blood flow Increase oxygen supply
Ca channel Blockers Reduction on peripheral resistance ( Secondary to dilatation of aorta ) Decrease blood pressure Decrease after load  Decrease workload  Decrease oxygen consumption
Most commonly used Ca Channel Blockers Nifedipine Verafamil Diltiazem Pharmacokineticss Drugs Onset of action Peak of action Half-life Nifedipine 20 minutes   1 hour   3-4 hours   Verafamil   1-2 hours   5 hours   8-10 hours Diltiazem   15 minutes   30 minutes   3-4 hours   Nicardifine   20 minutes   45 minutes   2-4 hours   Felodipine   2-5 hours   6-7 hours   11-16 hour
Unwanted effect Nausea and vomiting Dizzyness Flushing of the face Tachycardia – due to hypotension Contraindications Cardiogenic shock Recent myocardial infarction Heart failure Atrio-ventricular block
Combination Theraphy Nitrates and B-blockers * The additive efficacy  is primarily a result of one drug blocking the adverse effect of the other agent on net myocardial oxygen consumption * B-blockers – blocks the reflex tachycardia associated with nitrates * Nitrates – attenuate the increase in the left ventricular end  diastolic volume associated with B-lockers by increasing venous capacitance
Ca channel blockers and B-blockers * useful in the treatment of  exertional angina that is not controlled adequately with nitrates and B-blockers * B-blockers – attenuate  reflex tachycardia produce by nifedipine   * These  two drugs produce decrease blood pressure
Ca channel blockers and Nitrates * Useful  in severe vasospastic or exertional angina (particularly in patient with exertional angina with congestive heart failure and sick sinus syndrome) * Nitrates reduce preload and after load * Ca channels reduces the after load * Net effect is on reduction of oxygen demand
Triple drugs  –  Nitrate  +  Ca channel blockers  +  B-blockers *Useful  in patients with exertional angina not controlled by the administration of two types of anti-anginal agent *  Nifidipine – decrease after load Nitrates – decrease preload B-blockers – decrease heart rate &  myocardial contractility
Type of Angina Other Names Description Drug Therapy STABLE Classic Exertional Fixed Atherosclerotic Obstruction coronary artery Nitrates CCB B-blockers VARIANT Prinzmetal’s Vasospasmic Vasospasm at any time Nitrates CCB UNSTABLE Crescendo Combined effect Pre= MI Nitrates  CCB

Antianginal Drugs

  • 1.
  • 2.
    Definition of termsAngina Pectoris – is the principal symptoms of patient with ischemic heart disease. Manifested by sudden, severe, pressing substernal pain that often radiates to the left shoulder and along the flexor surface of the left arm. Usually precipitated by exercise, excitement or a heavy meal.
  • 3.
    Types of AnginaTypical Angina ( Classical Angina ) pain is commonly induced by exercise, excitement or a heavy meal secondary to advanced atherosclerosis of the coronary vessels associated with ST-segment depression on ECG
  • 4.
    Variant Angina (Prinzmetal Angina) pain is induced while at rest associated with ST-segment elevation on ECG secondary to vasospasm of the coronary vessels Unstable angina may involve coronary spasm and may also have the component of atherosclerosis the duration of manifestation is longer than the first two and has the manifestation of Myocardial infarction
  • 5.
    * Myocardialischemia which produces angina results from imbalances in myocardial oxygen supply & demand relationship such as decreased oxygen supply and/or increased oxygen demand. Etiology Decrease oxygen supply Increase demand for oxygen
  • 6.
    Determinant of MyocardialOxygen Supply Coronary blood flow Determined by: perfusion pressure duration of diastole coronary bed resistance Arterio-venous oxygen difference
  • 7.
    Determinant of MyocardialOxygen demand Major Determinants Wall stress  intraventricular pressure ventricular volume wall thickness Heart rate Contractility
  • 8.
    Determinants of VascularTone Relaxation of vascular smooth muscle by: Increase cGMP Decrease intracellular calcium Increase cAMP Stabilizing or preventing depolarization of the vascular smooth muscle cell membrane
  • 9.
    Treatment Plan: A.decrease the risk factor like atherosclerosis, hypertension, smoking B. increase oxygen supply C. decrease oxygen demand
  • 10.
    ANTIANGINAL DRUGS I.AGENTS WHICH ↓ O2 DEMAND & ↑ O2 SUPPLY A. NITRATES B. CALCIUM CHANNEL BLOCKERS II. AGENTS WHICH ↓ O2 DEMAND C. BETA BLOCKERS
  • 11.
    NITRATES AND NITRITESClassification of nitrates : Rapidly acting nitrates * used to terminate acute attack of angina * e.g.- Nitroglycerin and Amyl nitrate * usually administered sublingually Long acting nitrates * used to prevent an attack of angina * e.g. - Erythrytyl tetranitrate, Isosorbide dinitrate, Pentaerythrytol tetranitrate * administered orally or topically
  • 12.
    Nitrates Coronary arterydilatation Decrease coronary bed resistance (Relieved coronary vasospasm) Increase coronary blood flow Increase oxygen supply
  • 13.
    Nitrates Reduction onperipheral resistance (Secondary to dilatation of aorta) Decrease blood pressure Decrease after load Decrease workload Decrease oxygen consumption
  • 14.
    Nitrates Reduced venousreturn (Due to dilatation of the veins) Decrease left ventricular volume Decrease preload Decrease workload Decrease oxygen consumption
  • 15.
    Effects Coronary arterydilatation Reduction of peripheral arterial resistance – decrease after load Reduce venous return – decrease preload
  • 16.
    Potential Beneficial Effectsof Nitrates. Beneficial effects Results Decrease Ventricular vol. Decrease myocardial oxygen requirement Decrease arterial pressure Decrease ejection time Venodilatation of epicardial coronary art. Relief of coranary artery spasm Increase collateral flow due to venodilatation Increase perfusion to ischemic myocardium Decrease left ventricular pressure > decrease preload due to dilatation of the vein > decrease after load due to dilatation of the arteries Improved subendocardial perfusion
  • 17.
    Potential Deleterious EffectsDeleterious Effects Results Reflex tachycardia Increase myocardial oxygen requirement Reflex increase in contractility Decrease diastolic perfusion Decrease myocardial perfusion
  • 18.
    ROUTES OF ADMINISTRATION1. Sublingual route – rational and effective for the treatment of acute attacks of angina pectoris. Half-life depend only on the rate at which they are delivered to the liver. 2. Oral route – to provide convenient and prolonged prophylaxis against attacks of angina 3. Intravenous Route – useful in the treatment of coronary vasospasm and acute ischemic syndrome. 4. Topical route – used to provide gradual absorption of the drug for prolonged prophylactic purpose .
  • 19.
    Drug Usual singledose Route of administration Duration of action Short acting Nitroglycerin 0.15-1.2 mg sublingual 10 - 30 min Isosorbide dinitrate 2.5-5 mg sublingual 10 – 60 min Amyl nitrite 0.18 – 3 ml inhalation 3 – 5 min Long acting Nitroglycerin sustained action 6.5 – 13 mg q 6-8 hrs oral 6 – 8 hrs Nitroglycerin 2% ointment 1 – 1.5 inches q hr topical 3 – 6 hrs Niroglycerin slow released 1 –2 mg per 4 hrs Buccal mucosa 3 – 6 hrs Nitroglycerin slow released 10 – 25 mg /24hrs (one patch/day} transdermal 8 –10 hrs Isosorbide dinitrate 2.5 – 10 mg per 2 hrs sublingual 1.5 – 2 hrs Isosorbide dinitrate 10 –60 mg per 4-6 hrs oral 4 – 6 hrs Isosorbide dinitrate chewable 5 – 10 mg per 2-4 hrs oral 2 – 3 hrs Isosorbide mononitrate 20 mg per 12 hrs oral 6 –10 hrs
  • 20.
    Adverse Effects Throbbingheadache Flushing of the face Dizziness – especially at the beginning of treatment Postural Hypotension – due to pooling of blood in the dependent portion of the body
  • 21.
    Contraindication Renal ischemiaAcute myocardial infarction Patients receiving other antihypertensive agent
  • 22.
    B-Blockers Hemodynamics Effects  Decrease heart rate Reduced blood pressure and cardiac contractility without appreciable decrease in cardiac output
  • 23.
    B-Blockers Decrease heartrate & Contractility Increase duration of diastole Decrease workload Increase coronary blood flow Decrease O 2 consumption Increase oxygen supply
  • 24.
    Contraindication Congestive heartfailure Asthma Complete heart block
  • 25.
    Ca - ChannelBlockers Effects Coronary artery dilatation Reduction on peripheral arterial resistance – decrease after load
  • 26.
    Ca Channel BlockersCoronary artery dilatation Decrease coronary bed resistance (Relieved coronary vasospasm) Increase coronary blood flow Increase oxygen supply
  • 27.
    Ca channel BlockersReduction on peripheral resistance ( Secondary to dilatation of aorta ) Decrease blood pressure Decrease after load Decrease workload Decrease oxygen consumption
  • 28.
    Most commonly usedCa Channel Blockers Nifedipine Verafamil Diltiazem Pharmacokineticss Drugs Onset of action Peak of action Half-life Nifedipine 20 minutes 1 hour 3-4 hours Verafamil 1-2 hours 5 hours 8-10 hours Diltiazem 15 minutes 30 minutes 3-4 hours Nicardifine 20 minutes 45 minutes 2-4 hours Felodipine 2-5 hours 6-7 hours 11-16 hour
  • 29.
    Unwanted effect Nauseaand vomiting Dizzyness Flushing of the face Tachycardia – due to hypotension Contraindications Cardiogenic shock Recent myocardial infarction Heart failure Atrio-ventricular block
  • 30.
    Combination Theraphy Nitratesand B-blockers * The additive efficacy is primarily a result of one drug blocking the adverse effect of the other agent on net myocardial oxygen consumption * B-blockers – blocks the reflex tachycardia associated with nitrates * Nitrates – attenuate the increase in the left ventricular end diastolic volume associated with B-lockers by increasing venous capacitance
  • 31.
    Ca channel blockersand B-blockers * useful in the treatment of exertional angina that is not controlled adequately with nitrates and B-blockers * B-blockers – attenuate reflex tachycardia produce by nifedipine * These two drugs produce decrease blood pressure
  • 32.
    Ca channel blockersand Nitrates * Useful in severe vasospastic or exertional angina (particularly in patient with exertional angina with congestive heart failure and sick sinus syndrome) * Nitrates reduce preload and after load * Ca channels reduces the after load * Net effect is on reduction of oxygen demand
  • 33.
    Triple drugs – Nitrate + Ca channel blockers + B-blockers *Useful in patients with exertional angina not controlled by the administration of two types of anti-anginal agent * Nifidipine – decrease after load Nitrates – decrease preload B-blockers – decrease heart rate & myocardial contractility
  • 34.
    Type of AnginaOther Names Description Drug Therapy STABLE Classic Exertional Fixed Atherosclerotic Obstruction coronary artery Nitrates CCB B-blockers VARIANT Prinzmetal’s Vasospasmic Vasospasm at any time Nitrates CCB UNSTABLE Crescendo Combined effect Pre= MI Nitrates CCB